Global Report: A Hope and a Payer - Pharmaceutical Executive

ADVERTISEMENT
Global Report: A Hope and a Payer
If current trends continue, the United Kingdom will spend 12.7 percent of its GDP on healthcare by 2050. Maybe that means it's time to reform the National Health Service's notoriously complex drug payment scheme.
May 1, 2006
By: Sarah Houlton
Pharmaceutical Executive

« Previous
12

Sarah Houlton, PhD, is Pharmaceutical Executive's global correspondent. She can be reached at sarah@owlmedia.co.uk

« Previous
12

ADVERTISEMENT

About the Author

Sarah Houlton

Sarah Houlton, PhD, is Pharmaceutical Executive’s international correspondent. Articles by Sarah Houlton
blog comments powered by Disqus
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma Careers
Featured Jobs

More Jobs
Source: Pharmaceutical Executive, 5/1/2006
 Click here